Erica Jordan Revance Therapeutics, Inc. (RVNC) insider trading activity

RVNC Quotes by TradingView

Erica Jordan is Chief Commercial Officer of Revance Therapeutics, Inc.. Currently has a direct ownership of 0 shares of RVNC, which is worth approximately $0. The most recent transaction as insider was on Feb 06, 2025, when has been sold 107,942 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

Erica Jordan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 06 2025
SELL
Sale (or disposition) back to the issuer
-
107,942 Reduced 100.0%
0 Common Stock
Feb 04 2025
SELL
Disposition due to a tender of shares in a change of control transaction
$25,265 $3.65 p/Share
6,922 Reduced 6.03%
107,942 Common Stock
Apr 16 2024
SELL
Open market or private sale
$9,089 $3.8 p/Share
2,392 Reduced 2.04%
114,864 Common Stock
EJ

Erica Jordan

Chief Commercial Officer
Nashville, TN

Track Institutional and Insider Activities on RVNC

Follow Revance Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

News

Receive news related to Revance Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RVNC